Erratum
After publication of [1] it came to the authors’ attention that in the abstract. The sentence “In the present study, we show that S100A7 significantly downregulates the expression of miR-29b in Estrogen Receptor (ER)-positive breast cancer cells (represented by MCF7), and significantly upregulates miR-29b in ER-negative cells (represented by MDA-MB-231)”. Was Incorrect, the correct statement is “In the present study, we show that S100A7 significantly upregulates the expression of miR-29b in Estrogen Receptor (ER)-positive breast cancer cells (represented by MCF7), and significantly downregulates miR-29b in ER-negative cells (represented by MDA-MB-231)”.
Reference
Zhao H, Wilkie T, Deol Y, Sneh A, Ganju A, Basree M, et al. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Mol Cancer. 2015;14:11.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found under doi:10.1186/s12943-014-0275-z.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Zhao, H., Wilkie, T., Deol, Y. et al. Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Mol Cancer 14, 195 (2015). https://doi.org/10.1186/s12943-015-0451-9
Published:
DOI: https://doi.org/10.1186/s12943-015-0451-9